CryoPort, Inc.
CYRX
Jodie situation report
CryoPort, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- CYRX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if CYRX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind CYRX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BXBlackstone Inc.investeeNov 6, 2025 ▾
“The paid-in-kind dividend relates to the private placement of Series C Preferred Stock with Blackstone.”
AZTAAzenta, Inc.competitorMar 5, 2026 ▾
“Life Sciences Products competition is with companies offering cryogenic systems products such as Azenta Life Sciences, Phase 2, and IC Biomedical.”
CORCencora, Inc.competitorMar 5, 2026 ▾
“Life Sciences Services competition is primarily with specialty couriers, who fall into the category of coopetition and include companies such as World Courier (a Cencora company), UPS Healthcare, Quick (a Kuehne+Nagel company), and Biocair.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CYRX is currently a Follower in the organic co-movement group RNA Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for CYRX; it is not active in the latest market snapshot.